Streetwise Medical Devices Articles



STAAR Shares Burst Higher after Firm Posts 77% Increase in Q2 Net Sales and Raises FY Outlook
Source: Streetwise Reports  (8/6/21)
Shares of STAAR Surgical Co. traded 20% higher after the company reported Q2/21 financial results highlighting a 93% YoY increase in net sales of its Implantable Collamer® Lenses. More >


Coverage Initiated on Company with a 'Genuine Physiological Heart Replacement Therapy'
Source: Streetwise Reports  (7/21/21)
The investment thesis for the device company Carmat, whose therapy "allows patients to live with almost normal quality of life," is presented in an H.C. Wainwright & Co. report. More >


Biopharma Partners with NIH to Advance Women's Hormone-Free Contraceptive
Source: Streetwise Reports  (7/21/21)
A Roth Capital Partners report calls this a "very cost-effective and strategic move" for Daré Bioscience. More >


Zynex Shares Rise as Firm Notches Significant Q2 Order Growth and Raises EBITDA Outlook
Source: Streetwise Reports  (7/16/21)
Zynex Inc. shares traded 10% higher after the electrotherapy medical device maker reported a 247% YoY growth in orders during Q2/21 and raised the range for its EBITDA estimates in the quarter by $1.2 million. More >


Pulse Bio Shares Beat Higher on Launch of CellFX NPS System in Canada
Source: Streetwise Reports  (7/1/21)
Pulse Biosciences shares traded 27% higher after the company announced it secured a $50 million private placement one day after it reported the first CellFX® procedure using its proprietary Nano-Pulse Stimulation technology had been performed in Canada. More >


Second Sight Shares Shine Brightly After Firm Posts Orion Study Results
Source: Streetwise Reports  (5/12/21)
Second Sight Medical Products Inc. shares traded 25% higher after the company reported the results from a two-year study of its Orion Visual Cortical Prosthesis System. More >


AbbVie's Allergan Aesthetics to Acquire Soliton for $550 Million
Source: Streetwise Reports  (5/10/21)
Soliton Inc. shares traded 25% higher after the company reported it had agreed to be acquired by AbbVie Inc.'s Allergan Aesthetics for $22.60 per share in an all cash transaction. More >


CryoLife Shares Trade 18% Higher on Q1 Financial Results
Source: Streetwise Reports  (4/30/21)
Shares of CryoLife Inc. set a new 52-week high intraday price after the company reported that total revenues in Q1/21 increased by 7% YoY to $71.1 million. More >


Nano-X Imaging Receives Go Ahead from FDA for Single Source Digital X-Ray
Source: Streetwise Reports  (4/5/21)
Shares of Nano-X Imaging Ltd. traded 17% higher after the company reported that the FDA has granted 510(k) approval for its single source ARC digital x-ray. More >


Shockwave Medical Reports 100% Increase in Preliminary Q1 Revenue
Source: Streetwise Reports  (3/30/21)
Shockwave Medical Inc. shares gained 19% after the company announced that sales of its recently launched C2 Coronary IVL System are growing steadily and are driving revenue growth. More >


Investors Seeing Green as FDA Approves Second Sight Medical's Argus 2s Retinal Prosthesis System
Source: Streetwise Reports  (3/5/21)
Second Sight Medical Products shares trade more than 400% higher after the company reported that the FDA granted approval for its Argus 2s Retinal Prosthesis System designed to deliver useful artificial vision to blind individuals diagnosed with retinitis pigmentosa. More >


FDA Grants Expanded Use in General Surgery for Asensus Surgical's Robotic Laparoscopic Platform
Source: Streetwise Reports  (3/3/21)
Asensus Surgical shares traded 16.5% higher after the company reported it received clearance from the U.S. Food & Drug Administration for its Senhance© Surgical System for use in general surgical procedures. More >


Virtual HealthCare Tech Firm Contracts to Provide Patient Care Platform to US Nephrology Clinic
Source: Streetwise Reports  (2/26/21)
Reliq Health Technologies reported it signed a new agreement with a Texas-based nephrology clinic to provide its iUGO Care platform to patients with chronic kidney disease. More >


Owens & Minor Shares Soar 36% After Firm Reports Record Q4 Earnings and Positive 2021 Outlook
Source: Streetwise Reports  (2/24/21)
Shares of Owens & Minor Inc. soared to a new 52-week high after the company reported Q4/20 and FY/20 financial results that were boosted by a 58% gain in global products revenue and increases in elective medical procedures. More >


Matt Badiali

Digital Therapeutics Leader DarioHealth Makes a Critical Acquisition
Source: Matt Badiali for Streetwise Reports  (2/17/21)
Independent financial analyst Matt Badiali discusses DarioHealth's latest acquisition and what it means for the company's growth. More >


PAVmed Shares Increase 28% after First US Patient Treated with CarpX Device for Carpal Tunnel Syndrome
Source: Streetwise Reports  (2/16/21)
PAVmed Inc. shares reached a new 52-week high after the company reported that the first patient in the U.S. was successfully treated with its CarpX® Device, a minimally invasive carpal tunnel release surgical instrument. More >


Align Technology Shares Grind 12.5% Higher after Firm Posts Record Q4 Revenue of $834.5 Million
Source: Streetwise Reports  (2/4/21)
Align Technology shares set a new 52-week high after the company announced financial results that included record FY/20 total revenues of $2.5 billion. More >


Abiomed Shares Gain 8% After Firm Announces Record Q3 Revenue of $232 Million
Source: Streetwise Reports  (1/28/21)
Shares of cardiac medical device maker Abiomed Inc. traded higher after the company reported record revenue for Q3/21 despite the impact from COVID-19. More >


Avinger Shares Rise 40% on Launch of Image-Guided Device to Diagnose and Treat PAD
Source: Streetwise Reports  (1/15/21)
Shares of Avinger Inc. reached a new 52-week high after the company reported it initiated a full commercial launch of its Tigereyeâ„¢ Image-Guided CTO Crossing Catheter system for diagnosing and treating peripheral artery disease. More >


Inari Shares Flow 14% Higher on Triple Digit YoY Growth in Procedures and Revenues
Source: Streetwise Reports  (1/13/21)
Shares of Inari Medical Inc. established a new 52-week high after the company reported that preliminary revenue in Q4/20 increased year-over-year by greater than 140%. More >


Biotech Collaborates to Advance Psychedelics Use in Cancer, Other Applications
Source: Streetwise Reports  (11/23/20)
Revive Therapeutics enters an agreement with PharmaTher, a specialty psychedelics pharmaceutical firm. More >


Glaukos Shares Pressured Higher After Firm Reports 11% Rise in Q3 Revenue
Source: Streetwise Reports  (11/6/20)
Shares of Glaukos Corp. traded 9% higher after the company reported Q3/20 financial results that included an 11% YoY increase in glaucoma and corneal health net sales. More >


Inspire Medical's Shareholders Rest Comfortably on Q3 Earnings and Raised FY Outlook
Source: Streetwise Reports  (11/3/20)
Shares of Inspire Medical Systems traded 30% higher and set a new 52-week high after the company reported Q3/20 financial results that included a 72% rise in YoY revenue. More >


Align Technology Shares Head Straight Up on 20.9% Q3 Revenue Growth as Firm Celebrates its 9 Millionth Invisalign Patient
Source: Streetwise Reports  (10/22/20)
Shares of Align Technology traded 35% higher and climbed to a new 52-week high after the company reported Q3/20 financial results that included a 20.9% YoY increase in net revenues. More >


U.S. Medical Device Firm to Acquire Developer of Dissection Stent
Source: Streetwise Reports  (9/9/20)
The specifics of the deal and the next steps for CryoLife are presented in a Ladenburg Thalmann report. More >


Showing Results: 51 to 75 of 299 Prev Next

Notable Quotes

"WEX is a new name in my letter."
– Chen Lin, What Is Chen Buying? What Is Chen Selling?
"DC is rated an immediate Strong Buy."
– Clive Maund, CliveMaund.com

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts